Somatic mutations in chromatin remodeler genes could modify the epigenomic landscape of CLL, but they are unusual In this particular malignancy when compared with other lymphoid neoplasms. CHD2 In spite of all recent therapeutic advancements, a proportion of patients will even now fail to respond